Related Experiment Videos
Neonatal familial hypercholesterolemia
Insights
Neonatal screening can identify infants with familial hypercholesterolemia, a genetic condition. Early diagnosis enables timely intervention to prevent premature heart disease in high-risk newborns.
Area of Science:
- Pediatrics
- Genetics
- Cardiology
Background:
- Familial hypercholesterolemia (FH) is a genetic disorder leading to high cholesterol levels.
- Individuals with FH have a significantly increased risk of premature ischemic heart disease.
- Early identification of FH is crucial for initiating preventative measures.
Purpose of the Study:
- To evaluate the feasibility and outcomes of neonatal screening for familial hypercholesterolemia.
- To assess cholesterol levels in neonates from hypercholesterolemic families.
- To determine the potential for primary prevention of heart disease in this high-risk group.
Main Methods:
- Studied hypercholesterolemic and normal neonates from affected families over 6 to 30 months.
- Monitored plasma cholesterol levels at various ages (6, 12, 18 months).
- Assessed the impact of low cholesterol intake on cholesterol levels in affected infants.
Main Results:
- 16 of 22 hypercholesterolemic neonates and 8 of 11 normal neonates had FH.
- Elevated cholesterol (>200 mg/100 ml) was observed in 8/16 hypercholesterolemic neonates by 6-12 months.
- Dietary intervention normalized cholesterol in 5/7 affected infants by 6-12 months.
Conclusions:
- Neonatal diagnosis of FH is possible and identifies infants at high genetic risk.
- Early detection facilitates primary prevention strategies for ischemic heart disease.
- Intervention, including dietary changes, can help manage cholesterol levels in affected infants.
Abstract:
Hypercholesterolemic and normal neonates from hypercholesterolemic kindreds were studied for 6 to 30 months. Sixteen of 22 hypercholesterolemic neonates and eight of 11 normal neonates came from families with "monogenic" hyperlipoproteinemia. At 6 or 12 months of age, plasma cholesterol level was greater than 200 mg/100 ml in eight of the 16 neonates with hypercholesterolemia. Four of these eight had cholesterol levels greater than or equal to 290 mg/100 ml at ages 6 to 18 months. On low cholesterol intake, at ages 6 to 12 months, five of seven infants with hypercholesterolemia had cholesterol levels less than 200 mg/100 ml. One of eight normal neonates from families with hypercholesterolemia had cholesterol levels greater than 200 mg/100 ml at ages 6 to 12 months. Neonatal diagnosis of familial hypercholesterolemia provides an opportunity for long-term primary prevention in a group at high genetic risk for premature is chemic heart disease.